Starpharma Holdings Ltd. | Income Statement
Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
273.00
804.00
3,767.00
2,992.00
3,812.00
SG&A Expense
19,007.00
22,899.00
28,791.00
21,778.00
18,987.00
EBIT
19,830.00
23,316.00
-
19,104.00
15,486.00
Non Operating Income/Expense
7.00
4.00
122.00
15.00
73.00
Interest Expense
7.00
5.00
2.00
1.00
-
Pretax Income
18,857.00
22,428.00
24,513.00
18,469.00
14,341.00
Income Tax
4,222.00
3,478.00
3,221.00
3,252.00
4,056.00
Consolidated Net Income
14,635.00
18,950.00
21,292.00
15,217.00
10,285.00
Net Income
14,635.00
18,950.00
21,292.00
15,217.00
10,285.00
Net Income After Extraordinaries
14,635.00
18,950.00
19,909.00
38,634.00
10,285.00
Net Income Available to Common
14,635.00
18,950.00
22,675.00
16,465.00
10,285.00
EPS (Basic)
0.05
0.06
0.07
0.02
0.03
Basic Shares Outstanding
284,414.80
310,143.80
345,043.20
368,164.50
370,136.60
EPS (Diluted)
0.05
0.06
0.07
0.02
0.03
Diluted Shares Outstanding
284,414.80
310,143.80
345,043.20
368,164.50
370,136.60
EBITDA
18,734.00
22,095.00
25,024.00
18,786.00
15,175.00
Non-Operating Interest Income
973.00
889.00
679.00
651.00
1,072.00
About Starpharma Holdings
View Profile
